跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IZBA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IZBA
Authorized
STANDARD
IZBA
novartis pharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
14fab902fcb5ea9d
Company
novartis pharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
14fab902fcb5ea9d
Drug Approval Canada Name
IZBA
Product Name
IZBA
Status
Marketed
Status Date
2018-04-03
Original Market Date
2017-02-06
Din
02457997
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.28
Atc Original
S01EE04 TRAVOPROST
Atc Name
s 01 ee 04
Aig Number
0145801002
Company Name
novartis pharmaceuticals canada inc
Company Address
100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1
Active Ingredients
TRAVOPROST
0.003 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
14fab902fcb5ea9d
Type
Standard
Back to Health Canada Approvals